# Mesa Verde Venture Partners

Mesa Verde Venture Partners is a Venture Capital based in San Diego, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** 4225 Executive Square, Suite 600, La Jolla, CA 92037, United States
- **Founded:** 2006
- **Assets under management:** Undisclosed
- **Website:** www.mesaverdevp.com
- **LinkedIn:** https://www.linkedin.com/company/mesa-verde-venture-partners

## Regulatory record

- **Reports private funds:** No

## About

Mesa Verde Venture Partners is an early-stage life sciences venture capital firm founded in 2006 in La Jolla, California. The firm invests in early-stage biomedical companies across pharmaceuticals, medical devices, diagnostics, life science enabling tools, and digital health. It has made 36 investments and 10 portfolio exits, with its latest investment in Acurion and exit in Medipacs.

## Sectors

- Digital Health
- Healthcare Services

## Questions

### What investment stages does Mesa Verde Venture Partners target?

Mesa Verde targets the earliest phases of company formation: seed-stage and start-up-stage life-science companies. The firm describes its mission as creating partnerships with entrepreneurs to build successful biomedical companies from inception.

### Which sectors does Mesa Verde explicitly invest in?

The firm invests across pharmaceuticals, medical devices, diagnostics, life-science enabling tools, and digital health. Its disclosed exits confirm activity in dermatology, diagnostics, CNS therapeutics, genomics, and anti-infectives.

### What is Mesa Verde's geographic focus?

Mesa Verde deliberately concentrates on Southern California, the Southwest, and other regions it describes as traditionally underrepresented in life-science venture capital. This is a foundational element of its sourcing strategy, distinguishing it from firms centered on the Boston–San Francisco corridor.

### Who runs investment decisions at Mesa Verde Venture Partners?

The firm is led by three Managing Directors, supported by a group of advisors and partners with experience building and investing in early-stage life-science companies. Mesa Verde does not publicly name its Managing Directors on its website or LinkedIn as of the latest Altss review.

### How does Mesa Verde source its deal flow?

The firm relies on its San Diego location and deep regional ties to academic research institutions, university systems, and entrepreneurial networks in Southern California and the Southwest — markets where life-science venture capital has historically been less concentrated than in Boston or the Bay Area.

### What is Mesa Verde's track record on exits?

The firm discloses at least nine exited portfolio companies, all acquired by strategic buyers including Galderma, Exact Sciences (two companies), Supernus, Sunovion, Bionano Genomics, Allergan, Mirum Pharma, Merck, and Nabriva Therapeutics. These exits span dermatology, diagnostics, CNS, genomics, and anti-infectives.

### Does Mesa Verde participate in fund commitments or only direct deals?

Mesa Verde describes itself as an early-stage venture capital firm that invests directly in seed- and start-up-stage life-science companies. Its public materials do not specify whether it makes fund commitments, GP stakes, or secondary investments.

## Related profiles

- [Merus Capital](https://altss.com/profile/merus-capital)
- [Mesco](https://altss.com/profile/mesco)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mesa-verde-venture-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology